nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—HTR2A—Parkinson's disease	0.454	0.522	CbGaD
Cyclobenzaprine—CYP2D6—Parkinson's disease	0.416	0.478	CbGaD
Cyclobenzaprine—HTR2A—enteric nervous system—Parkinson's disease	0.0113	0.157	CbGeAlD
Cyclobenzaprine—HTR2A—myenteric nerve plexus—Parkinson's disease	0.00859	0.119	CbGeAlD
Cyclobenzaprine—HTR2A—locus ceruleus—Parkinson's disease	0.00748	0.103	CbGeAlD
Cyclobenzaprine—HTR2A—cerebellar cortex—Parkinson's disease	0.0061	0.0843	CbGeAlD
Cyclobenzaprine—HTR2A—sympathetic nervous system—Parkinson's disease	0.00592	0.0818	CbGeAlD
Cyclobenzaprine—HTR2A—pons—Parkinson's disease	0.00431	0.0596	CbGeAlD
Cyclobenzaprine—HTR2A—autonomic nervous system—Parkinson's disease	0.00398	0.055	CbGeAlD
Cyclobenzaprine—HTR2A—telencephalic ventricle—Parkinson's disease	0.00355	0.0491	CbGeAlD
Cyclobenzaprine—HTR2A—peripheral nervous system—Parkinson's disease	0.00287	0.0397	CbGeAlD
Cyclobenzaprine—HTR2A—nerve—Parkinson's disease	0.00224	0.0309	CbGeAlD
Cyclobenzaprine—HTR2A—hindbrain—Parkinson's disease	0.00168	0.0232	CbGeAlD
Cyclobenzaprine—CYP2D6—hindbrain—Parkinson's disease	0.00153	0.0211	CbGeAlD
Cyclobenzaprine—HTR2A—embryo—Parkinson's disease	0.00105	0.0145	CbGeAlD
Cyclobenzaprine—HTR2A—brainstem—Parkinson's disease	0.00096	0.0133	CbGeAlD
Cyclobenzaprine—HTR2A—forebrain—Parkinson's disease	0.000927	0.0128	CbGeAlD
Cyclobenzaprine—CYP2D6—brainstem—Parkinson's disease	0.000875	0.0121	CbGeAlD
Cyclobenzaprine—CYP2D6—forebrain—Parkinson's disease	0.000844	0.0117	CbGeAlD
Cyclobenzaprine—HTR2A—cardiovascular system—Parkinson's disease	0.000784	0.0108	CbGeAlD
Cyclobenzaprine—HTR2A—medulla oblongata—Parkinson's disease	0.00067	0.00926	CbGeAlD
Cyclobenzaprine—Benzphetamine—SLC18A2—Parkinson's disease	0.000617	0.0696	CrCbGaD
Cyclobenzaprine—HTR2A—midbrain—Parkinson's disease	0.000612	0.00846	CbGeAlD
Cyclobenzaprine—HTR2A—spinal cord—Parkinson's disease	0.000597	0.00825	CbGeAlD
Cyclobenzaprine—HTR2A—head—Parkinson's disease	0.000531	0.00733	CbGeAlD
Cyclobenzaprine—HTR2A—nervous system—Parkinson's disease	0.000503	0.00695	CbGeAlD
Cyclobenzaprine—HTR2A—central nervous system—Parkinson's disease	0.000484	0.0067	CbGeAlD
Cyclobenzaprine—CYP2D6—head—Parkinson's disease	0.000483	0.00668	CbGeAlD
Cyclobenzaprine—HTR2A—cerebellum—Parkinson's disease	0.000473	0.00654	CbGeAlD
Cyclobenzaprine—CYP3A4—nervous system—Parkinson's disease	0.000466	0.00644	CbGeAlD
Cyclobenzaprine—CYP2D6—nervous system—Parkinson's disease	0.000458	0.00634	CbGeAlD
Cyclobenzaprine—CYP3A4—central nervous system—Parkinson's disease	0.000448	0.0062	CbGeAlD
Cyclobenzaprine—CYP2D6—central nervous system—Parkinson's disease	0.000441	0.0061	CbGeAlD
Cyclobenzaprine—CYP2D6—cerebellum—Parkinson's disease	0.000431	0.00596	CbGeAlD
Cyclobenzaprine—HTR2A—brain—Parkinson's disease	0.000385	0.00532	CbGeAlD
Cyclobenzaprine—CYP2D6—brain—Parkinson's disease	0.00035	0.00484	CbGeAlD
Cyclobenzaprine—Protriptyline—CYP2D6—Parkinson's disease	0.000304	0.0343	CrCbGaD
Cyclobenzaprine—Cyproheptadine—HTR1A—Parkinson's disease	0.000287	0.0323	CrCbGaD
Cyclobenzaprine—Tripelennamine—CYP2D6—Parkinson's disease	0.000273	0.0308	CrCbGaD
Cyclobenzaprine—Benzphetamine—SLC6A3—Parkinson's disease	0.000256	0.0289	CrCbGaD
Cyclobenzaprine—Cyproheptadine—DRD2—Parkinson's disease	0.000244	0.0275	CrCbGaD
Cyclobenzaprine—Chlorprothixene—DRD3—Parkinson's disease	0.000243	0.0274	CrCbGaD
Cyclobenzaprine—Chlorprothixene—DRD1—Parkinson's disease	0.000238	0.0269	CrCbGaD
Cyclobenzaprine—Protriptyline—ABCB1—Parkinson's disease	0.000217	0.0245	CrCbGaD
Cyclobenzaprine—Trimipramine—SLC6A3—Parkinson's disease	0.000209	0.0235	CrCbGaD
Cyclobenzaprine—Nortriptyline—HTR1A—Parkinson's disease	0.000194	0.0219	CrCbGaD
Cyclobenzaprine—Cyproheptadine—HTR2A—Parkinson's disease	0.000188	0.0212	CrCbGaD
Cyclobenzaprine—Promazine—DRD1—Parkinson's disease	0.000187	0.021	CrCbGaD
Cyclobenzaprine—Trimipramine—HTR1A—Parkinson's disease	0.000183	0.0206	CrCbGaD
Cyclobenzaprine—Imipramine—HTR7—Parkinson's disease	0.000177	0.02	CrCbGaD
Cyclobenzaprine—Amitriptyline—HTR7—Parkinson's disease	0.000176	0.0198	CrCbGaD
Cyclobenzaprine—Doxepin—HTR1A—Parkinson's disease	0.000174	0.0197	CrCbGaD
Cyclobenzaprine—Chlorprothixene—DRD2—Parkinson's disease	0.000168	0.0189	CrCbGaD
Cyclobenzaprine—Amitriptyline—DRD3—Parkinson's disease	0.000165	0.0186	CrCbGaD
Cyclobenzaprine—Nortriptyline—DRD2—Parkinson's disease	0.000165	0.0186	CrCbGaD
Cyclobenzaprine—Nortriptyline—CYP2E1—Parkinson's disease	0.000159	0.0179	CrCbGaD
Cyclobenzaprine—Trimipramine—DRD2—Parkinson's disease	0.000155	0.0175	CrCbGaD
Cyclobenzaprine—Imipramine—SLC6A3—Parkinson's disease	0.000155	0.0175	CrCbGaD
Cyclobenzaprine—Promethazine—DRD2—Parkinson's disease	0.00015	0.0169	CrCbGaD
Cyclobenzaprine—Doxepin—DRD2—Parkinson's disease	0.000148	0.0167	CrCbGaD
Cyclobenzaprine—Tamoxifen—CYP2E1—Parkinson's disease	0.000143	0.0161	CrCbGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—GSTA4—Parkinson's disease	0.000143	0.00292	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000142	0.0029	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000141	0.00288	CbGpPWpGaD
Cyclobenzaprine—Orphenadrine—CYP2E1—Parkinson's disease	0.000139	0.0157	CrCbGaD
Cyclobenzaprine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000138	0.00282	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.000138	0.00282	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—Parkinson's disease	0.000136	0.00279	CbGpPWpGaD
Cyclobenzaprine—Imipramine—HTR1A—Parkinson's disease	0.000136	0.0153	CrCbGaD
Cyclobenzaprine—Amitriptyline—HTR1A—Parkinson's disease	0.000135	0.0152	CrCbGaD
Cyclobenzaprine—HTR2A—G alpha (q) signalling events—ADRBK1—Parkinson's disease	0.000135	0.00276	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000134	0.00274	CbGpPWpGaD
Cyclobenzaprine—Promazine—DRD2—Parkinson's disease	0.000132	0.0148	CrCbGaD
Cyclobenzaprine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000131	0.00269	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—GRM4—Parkinson's disease	0.000131	0.00268	CbGpPWpGaD
Cyclobenzaprine—Chlorprothixene—HTR2A—Parkinson's disease	0.00013	0.0146	CrCbGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.00013	0.00266	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00013	0.00265	CbGpPWpGaD
Cyclobenzaprine—Nortriptyline—HTR2A—Parkinson's disease	0.000127	0.0144	CrCbGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—MAOB—Parkinson's disease	0.000127	0.00261	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.000125	0.00256	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—PENK—Parkinson's disease	0.000124	0.00254	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—GSTA4—Parkinson's disease	0.000121	0.00248	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—Parkinson's disease	0.000121	0.00247	CbGpPWpGaD
Cyclobenzaprine—Trimipramine—HTR2A—Parkinson's disease	0.00012	0.0135	CrCbGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.000119	0.00245	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000119	0.00244	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.000118	0.00241	CbGpPWpGaD
Cyclobenzaprine—Nortriptyline—CYP2D6—Parkinson's disease	0.000117	0.0131	CrCbGaD
Cyclobenzaprine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000116	0.00238	CbGpPWpGaD
Cyclobenzaprine—Promethazine—HTR2A—Parkinson's disease	0.000116	0.013	CrCbGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.000115	0.00236	CbGpPWpGaD
Cyclobenzaprine—Imipramine—DRD2—Parkinson's disease	0.000115	0.013	CrCbGaD
Cyclobenzaprine—Amitriptyline—DRD2—Parkinson's disease	0.000114	0.0129	CrCbGaD
Cyclobenzaprine—Doxepin—HTR2A—Parkinson's disease	0.000114	0.0129	CrCbGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—PDYN—Parkinson's disease	0.000114	0.00233	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000113	0.00232	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.000112	0.00229	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000111	0.00228	CbGpPWpGaD
Cyclobenzaprine—Imipramine—CYP2E1—Parkinson's disease	0.000111	0.0125	CrCbGaD
Cyclobenzaprine—Amitriptyline—CYP2E1—Parkinson's disease	0.00011	0.0124	CrCbGaD
Cyclobenzaprine—Trimipramine—CYP2D6—Parkinson's disease	0.00011	0.0124	CrCbGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—DGKQ—Parkinson's disease	0.000109	0.00223	CbGpPWpGaD
Cyclobenzaprine—Diphenhydramine—CYP2D6—Parkinson's disease	0.000108	0.0121	CrCbGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—MAOB—Parkinson's disease	0.000108	0.00221	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000106	0.00218	CbGpPWpGaD
Cyclobenzaprine—Promethazine—CYP2D6—Parkinson's disease	0.000106	0.0119	CrCbGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—GRM5—Parkinson's disease	0.000106	0.00216	CbGpPWpGaD
Cyclobenzaprine—Tamoxifen—CYP2D6—Parkinson's disease	0.000105	0.0118	CrCbGaD
Cyclobenzaprine—Doxepin—CYP2D6—Parkinson's disease	0.000105	0.0118	CrCbGaD
Cyclobenzaprine—HTR2A—G alpha (q) signalling events—EDN1—Parkinson's disease	0.000105	0.00214	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Phase II conjugation—COMT—Parkinson's disease	0.000104	0.00213	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Phase II conjugation—GSTP1—Parkinson's disease	0.000103	0.00212	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.000102	0.00209	CbGpPWpGaD
Cyclobenzaprine—Promazine—HTR2A—Parkinson's disease	0.000102	0.0115	CrCbGaD
Cyclobenzaprine—Carbamazepine—ABCB1—Parkinson's disease	0.000101	0.0114	CrCbGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.000101	0.00207	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.000101	0.00207	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000101	0.00206	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—GPR37—Parkinson's disease	9.88e-05	0.00203	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—DGKQ—Parkinson's disease	9.88e-05	0.00203	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	9.88e-05	0.00202	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	9.56e-05	0.00196	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Phase II conjugation—GSTM1—Parkinson's disease	9.49e-05	0.00194	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	9.35e-05	0.00192	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	9.33e-05	0.00191	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	9.2e-05	0.00188	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PPP1R1B—Parkinson's disease	9.04e-05	0.00185	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—ADORA2A—Parkinson's disease	8.97e-05	0.00184	CbGpPWpGaD
Cyclobenzaprine—Imipramine—HTR2A—Parkinson's disease	8.9e-05	0.01	CrCbGaD
Cyclobenzaprine—Amitriptyline—HTR2A—Parkinson's disease	8.85e-05	0.00997	CrCbGaD
Cyclobenzaprine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	8.75e-05	0.00179	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	8.65e-05	0.00177	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	8.65e-05	0.00177	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	8.64e-05	0.00177	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	8.53e-05	0.00175	CbGpPWpGaD
Cyclobenzaprine—Chlorprothixene—ABCB1—Parkinson's disease	8.48e-05	0.00956	CrCbGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	8.36e-05	0.00171	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	8.31e-05	0.0017	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—GRK5—Parkinson's disease	8.25e-05	0.00169	CbGpPWpGaD
Cyclobenzaprine—Imipramine—CYP2D6—Parkinson's disease	8.14e-05	0.00918	CrCbGaD
Cyclobenzaprine—Amitriptyline—CYP2D6—Parkinson's disease	8.09e-05	0.00912	CrCbGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—CYP2D6—Parkinson's disease	8.01e-05	0.00164	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metapathway biotransformation—CYP2D6—Parkinson's disease	7.9e-05	0.00162	CbGpPWpGaD
Cyclobenzaprine—Trimipramine—ABCB1—Parkinson's disease	7.84e-05	0.00884	CrCbGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—HTR1A—Parkinson's disease	7.79e-05	0.0016	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—TAC1—Parkinson's disease	7.67e-05	0.00157	CbGpPWpGaD
Cyclobenzaprine—Promethazine—ABCB1—Parkinson's disease	7.55e-05	0.00851	CrCbGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—DRD1—Parkinson's disease	7.52e-05	0.00154	CbGpPWpGaD
Cyclobenzaprine—Tamoxifen—ABCB1—Parkinson's disease	7.49e-05	0.00845	CrCbGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—GRK5—Parkinson's disease	7.49e-05	0.00153	CbGpPWpGaD
Cyclobenzaprine—Doxepin—ABCB1—Parkinson's disease	7.47e-05	0.00842	CrCbGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—GRM4—Parkinson's disease	7.4e-05	0.00152	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	7.32e-05	0.0015	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—DRD3—Parkinson's disease	7.28e-05	0.00149	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	7.22e-05	0.00148	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—COMT—Parkinson's disease	7.16e-05	0.00147	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	7.13e-05	0.00146	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	7.11e-05	0.00146	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	7.06e-05	0.00145	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—VPS35—Parkinson's disease	7.05e-05	0.00144	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	7.03e-05	0.00144	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PENK—Parkinson's disease	7.01e-05	0.00144	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	6.92e-05	0.00142	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—GRM4—Parkinson's disease	6.72e-05	0.00138	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	6.7e-05	0.00137	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—HTR7—Parkinson's disease	6.59e-05	0.00135	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—DRD2—Parkinson's disease	6.59e-05	0.00135	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	6.55e-05	0.00134	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	6.46e-05	0.00132	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PDYN—Parkinson's disease	6.42e-05	0.00131	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PENK—Parkinson's disease	6.37e-05	0.00131	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	6.27e-05	0.00128	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	6.25e-05	0.00128	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	6.18e-05	0.00127	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	6.09e-05	0.00125	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—COMT—Parkinson's disease	6.07e-05	0.00124	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	6.07e-05	0.00124	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	6.07e-05	0.00124	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	6.04e-05	0.00124	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	6.03e-05	0.00123	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	5.98e-05	0.00123	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—GRM5—Parkinson's disease	5.96e-05	0.00122	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	5.96e-05	0.00122	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—DGKQ—Parkinson's disease	5.84e-05	0.0012	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GPR37—Parkinson's disease	5.84e-05	0.0012	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PDYN—Parkinson's disease	5.83e-05	0.00119	CbGpPWpGaD
Cyclobenzaprine—Imipramine—ABCB1—Parkinson's disease	5.81e-05	0.00655	CrCbGaD
Cyclobenzaprine—Amitriptyline—ABCB1—Parkinson's disease	5.78e-05	0.00651	CrCbGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	5.65e-05	0.00116	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	5.57e-05	0.00114	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	5.55e-05	0.00114	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	5.47e-05	0.00112	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—GRM5—Parkinson's disease	5.42e-05	0.00111	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PPP1R1B—Parkinson's disease	5.34e-05	0.00109	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—EDN1—Parkinson's disease	5.27e-05	0.00108	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—ADORA2A—Parkinson's disease	5.07e-05	0.00104	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—COMT—Parkinson's disease	4.68e-05	0.000959	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—RIT2—Parkinson's disease	4.67e-05	0.000956	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	4.66e-05	0.000955	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	4.65e-05	0.000953	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ND3—Parkinson's disease	4.64e-05	0.000952	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—MCCC1—Parkinson's disease	4.64e-05	0.000952	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	4.62e-05	0.000946	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—ADORA2A—Parkinson's disease	4.61e-05	0.000944	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	4.6e-05	0.000942	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—TNF—Parkinson's disease	4.55e-05	0.000932	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GRK5—Parkinson's disease	4.43e-05	0.000907	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—HTR1A—Parkinson's disease	4.4e-05	0.000902	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—TALDO1—Parkinson's disease	4.37e-05	0.000895	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—OMD—Parkinson's disease	4.37e-05	0.000895	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—TAC1—Parkinson's disease	4.33e-05	0.000888	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	4.28e-05	0.000878	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—DRD1—Parkinson's disease	4.25e-05	0.000871	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	4.22e-05	0.000866	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	4.18e-05	0.000856	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	4.14e-05	0.000848	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—DRD3—Parkinson's disease	4.12e-05	0.000843	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—HTR1A—Parkinson's disease	4e-05	0.000819	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GRM4—Parkinson's disease	3.97e-05	0.000813	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GCH1—Parkinson's disease	3.95e-05	0.000809	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—TAC1—Parkinson's disease	3.94e-05	0.000806	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—MCCC1—Parkinson's disease	3.93e-05	0.000806	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ND3—Parkinson's disease	3.93e-05	0.000806	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—DRD1—Parkinson's disease	3.86e-05	0.000791	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—ADRBK1—Parkinson's disease	3.84e-05	0.000787	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MAG—Parkinson's disease	3.76e-05	0.000771	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PENK—Parkinson's disease	3.76e-05	0.000771	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—DRD3—Parkinson's disease	3.74e-05	0.000766	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—DRD2—Parkinson's disease	3.72e-05	0.000763	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—HTR7—Parkinson's disease	3.72e-05	0.000763	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—TALDO1—Parkinson's disease	3.7e-05	0.000758	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—OMD—Parkinson's disease	3.7e-05	0.000758	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—IL6—Parkinson's disease	3.67e-05	0.000752	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GBA—Parkinson's disease	3.52e-05	0.000721	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—FBP1—Parkinson's disease	3.52e-05	0.000721	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—DBH—Parkinson's disease	3.52e-05	0.000721	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	3.51e-05	0.000719	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—ADRBK1—Parkinson's disease	3.49e-05	0.000715	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PDYN—Parkinson's disease	3.44e-05	0.000705	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—DRD2—Parkinson's disease	3.38e-05	0.000693	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—HTR7—Parkinson's disease	3.38e-05	0.000693	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GCH1—Parkinson's disease	3.35e-05	0.000686	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GFAP—Parkinson's disease	3.24e-05	0.000663	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GRM5—Parkinson's disease	3.2e-05	0.000656	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ND3—Parkinson's disease	3.04e-05	0.000622	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—MCCC1—Parkinson's disease	3.04e-05	0.000622	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	3.02e-05	0.000618	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—DBH—Parkinson's disease	2.98e-05	0.000611	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GBA—Parkinson's disease	2.98e-05	0.000611	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—FBP1—Parkinson's disease	2.98e-05	0.000611	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—EDN1—Parkinson's disease	2.98e-05	0.000611	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—OMD—Parkinson's disease	2.86e-05	0.000585	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—TALDO1—Parkinson's disease	2.86e-05	0.000585	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	2.84e-05	0.000582	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FGF20—Parkinson's disease	2.81e-05	0.000575	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ADORA2A—Parkinson's disease	2.72e-05	0.000557	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	2.71e-05	0.000555	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—EDN1—Parkinson's disease	2.71e-05	0.000554	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—DDC—Parkinson's disease	2.58e-05	0.000529	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GCH1—Parkinson's disease	2.58e-05	0.000529	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—INSR—Parkinson's disease	2.51e-05	0.000514	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	2.44e-05	0.0005	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FGB—Parkinson's disease	2.37e-05	0.000486	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HTR1A—Parkinson's disease	2.36e-05	0.000484	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TAC1—Parkinson's disease	2.32e-05	0.000476	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—DBH—Parkinson's disease	2.3e-05	0.000472	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GBA—Parkinson's disease	2.3e-05	0.000472	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—FBP1—Parkinson's disease	2.3e-05	0.000472	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—DRD1—Parkinson's disease	2.28e-05	0.000467	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—DRD3—Parkinson's disease	2.21e-05	0.000452	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	2.2e-05	0.00045	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—DDC—Parkinson's disease	2.19e-05	0.000448	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—MAOB—Parkinson's disease	2.17e-05	0.000446	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GSTA4—Parkinson's disease	2.07e-05	0.000424	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ADRBK1—Parkinson's disease	2.06e-05	0.000422	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.04e-05	0.000418	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HTR7—Parkinson's disease	2e-05	0.000409	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—DRD2—Parkinson's disease	2e-05	0.000409	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	1.86e-05	0.000381	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—MAOB—Parkinson's disease	1.84e-05	0.000377	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.75e-05	0.000359	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—DDC—Parkinson's disease	1.69e-05	0.000346	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	1.67e-05	0.000343	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	1.62e-05	0.000331	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	1.6e-05	0.000328	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.6e-05	0.000327	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.59e-05	0.000325	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.48e-05	0.000303	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—NGF—Parkinson's disease	1.47e-05	0.000301	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.46e-05	0.000299	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—TH—Parkinson's disease	1.44e-05	0.000295	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.44e-05	0.000294	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.42e-05	0.000291	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.38e-05	0.000283	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	1.37e-05	0.000281	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CTGF—Parkinson's disease	1.34e-05	0.000275	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—APOE—Parkinson's disease	1.3e-05	0.000266	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	1.25e-05	0.000257	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—NQO1—Parkinson's disease	1.24e-05	0.000254	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—COMT—Parkinson's disease	1.22e-05	0.000251	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—TH—Parkinson's disease	1.22e-05	0.00025	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.22e-05	0.00025	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.22e-05	0.000249	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.2e-05	0.000246	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CYCS—Parkinson's disease	1.17e-05	0.00024	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.15e-05	0.000236	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.12e-05	0.00023	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—INS—Parkinson's disease	1.11e-05	0.000228	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.07e-05	0.00022	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.06e-05	0.000217	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—COMT—Parkinson's disease	1.04e-05	0.000213	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.04e-05	0.000213	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GSTP1—Parkinson's disease	1.03e-05	0.000212	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—MAOA—Parkinson's disease	1.03e-05	0.000211	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—HMOX1—Parkinson's disease	1.02e-05	0.000209	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	9.9e-06	0.000203	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ABCB1—Parkinson's disease	9.78e-06	0.0002	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	9.67e-06	0.000198	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—NQO1—Parkinson's disease	9.56e-06	0.000196	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GSTM1—Parkinson's disease	9.49e-06	0.000194	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—TH—Parkinson's disease	9.42e-06	0.000193	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—APOE—Parkinson's disease	9.22e-06	0.000189	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GPX1—Parkinson's disease	9.09e-06	0.000186	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CYCS—Parkinson's disease	9.04e-06	0.000185	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—MTHFR—Parkinson's disease	8.39e-06	0.000172	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	8.27e-06	0.000169	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	8.22e-06	0.000168	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—COMT—Parkinson's disease	8.01e-06	0.000164	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	7.97e-06	0.000163	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—MAOA—Parkinson's disease	7.95e-06	0.000163	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—INS—Parkinson's disease	7.87e-06	0.000161	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	7.86e-06	0.000161	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—APOE—Parkinson's disease	7.81e-06	0.00016	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	7.6e-06	0.000156	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	7.55e-06	0.000155	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	7.32e-06	0.00015	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GPX1—Parkinson's disease	7.01e-06	0.000144	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—INS—Parkinson's disease	6.67e-06	0.000137	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	6.47e-06	0.000133	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—APOE—Parkinson's disease	6.03e-06	0.000123	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—INS—Parkinson's disease	5.15e-06	0.000105	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IL6—Parkinson's disease	4.85e-06	9.94e-05	CbGpPWpGaD
